How WorldUpstart Accelerates Your Entry into the U.S. Market 

For innovators across the Netherlands, Flanders, Denmark, and Sweden, the U.S. healthcare market offers unmatched scale, but it’s also one of the most complex in the world. 

Only one in five international life sciences companies succeeds in establishing meaningful U.S. traction. WorldUpstart, a Philadelphiabased accelerator, doubles your likelihood of success by providing a structured, riskreducing pathway for companies preparing to scale through clinical trials, pilots, or operational launch in Pennsylvania. 

A Gateway Built for International Life Sciences and MedTech Innovators 

The U.S. Market Gateway Accelerator is purposebuilt for global life sciences and MedTech companies. The program delivers tailored U.S. strategies with a focus on: 

• Regulatory navigation 

• Reimbursement clarity 

• Investor expectations 

• Commercialization pathways 

Highly curated sessions and expert mentoring compress months of work into weeks. Participants gain introductions to leading U.S. pharma companies, health systems, investors, commercialization partners, hospitals, payors, and regulatory advisors enabling European executives to efficiently test, validate, and scale in a competitive market. 

National Exposure, Not Just a Local Network 

Unlike programs tied to a single regional ecosystem, WorldUpstart provides nationallevel visibility and connections. The accelerator is delivered in a flexible hybrid format. 

Who Participates 

Recent cohorts include life sciences and MedTech companies from Europe, Asia, and Oceania, spanning digital health, drug development, imaging, medical devices, and therapeutic innovation. To date, WorldUpstart has supported more than 54 companies from 16 countries in successfully entering and growing in the U.S. market. 

If the U.S. Is on Your Strategic Roadmap, Start in Pennsylvania with WorldUpstart 

Learn more at www.worldupstart.com